Aldeyra Therapeutics, Inc. (ALDX)
4.875
+0.18
(+3.72%)
USD |
NASDAQ |
Dec 08, 15:12
Aldeyra Therapeutics Shareholders Equity (Quarterly): 49.24M for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 917.27M |
| Vanda Pharmaceuticals, Inc. | 466.00M |
| ADMA Biologics, Inc. | 431.19M |
| Exelixis, Inc. | 2.161B |
| Anavex Life Sciences Corp. | 94.87M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 77.80M |
| Total Liabilities (Quarterly) | 28.56M |
| Debt to Equity Ratio | 0.3156 |
| Current Ratio | 2.680 |
| Net Debt Paydown Yield | 0.01% |